Nucleolin is a well-known major non-ribosomal protein consisting of 710 amino acids in nucleolus: biochemically it is a ubiquitous phosphoprotein which serves as regulator of ribosomal biogenesis and maturation, including the control of ribosomal DNA (rDNA) transcription, pre-ribosome packaging, and organization of nucleolar chromatin. 1,2) We recently reported that TNF-a inducing protein (Tipa), a new carcinogenic factor (molecular weight of 19 kDa) which is transcribed from the TNF-a inducing protein (Tipa) gene in the genome of Helicobacter pylori (H. pylori) strain 26695, binds to nucleolin on the cell surface of mouse gastric cancer cell line : This finding provided a new mechanistic insight into gastric cancer development with Tipa mediated through nucleolin.Looking at the unique features of nucleolin in carcinogenesis, it has been reported that the amount of nucleolin is highly elevated in rapidly proliferating cells, such as cancer cell lines, and that nucleolin is a major component of the silver-stained nucleolar organizer region (AgNOR), which is also elevated in cancer cells compared with normal or premalignant cells. 2,6,7) The localization of nucleolin on the cell surface of gastric cancer cell lines attracted our attention because nucleolin had been mainly reported to be present in nucleoli: We discovered that significant amounts of nucleolin are present on the cell surface of gastric cancer cell lines, as determined by cell fractionation method and flow cytometry analysis with anti-nucleolin antibody.Since cell surface nucleolin serves as a receptor for various ligands, including midkine, lactoferrin, endostatin, and human immunodeficiency virus (HIV) particles, it is possible to regulate the cell growth by either a promoting ligand, like midkine, a cytokine regulating cell proliferation and differentiation, or inhibiting ligands, such as lactoferrin and endostatin.8-11) Considering our study of nucleolin on the cell surface, we think that a ligand with anticancer activity can be used to inhibit the growth of gastric cancer cells.The well-investigated anti-cancer aptamer named AS1411 is a DNA aptamer of 26-mer unmodified guanine-rich oligonucleotide; it specifically binds to nucleolin, resulting in inhibitions of nucleolin function and cancer cell growth in vitro and in vivo. 12,13) Since AS1411 is now in Phase II clinical trials as treatment for acute myeloid leukemia and renal cell carcinoma, we think it is worthwhile to study the effects of AS1411 on inhibition of cell growth and cell cycle regulation in gastric cancer cell lines. This manuscript is the first report that the amount of nucleolin is clearly elevated on the cell surface of gastric cancer cell lines, but not in normal mouse glandular stomach, and that AS1411 inhibits growth of gastric cancer cells probably mediated through cell surface nucleolin before it is incorporated into the cells. All the results indicate that nucleolin on the cell surface is a new molecular target for treatment of gastric cancer in humans. Nishihamaboji, Y...